Annie Coulson

1 day ago | biotechniques.com | Annie Coulson

Deleting a gene cluster in wheat leads to a new seed variety that could be less harmful to individuals with celiac disease. Researchers from the University of California, Davis (CA, USA), have targeted genes in wheat that underlie gluten protein production without affecting breadmaking quality. This work represents a promising step forward in celiac disease research; however, it does not mean that they have developed a celiac-safe form of wheat.

2 days ago | biotechniques.com | Annie Coulson

The impact of circadian disruption on muscle health and aging has been uncovered. A research team at King’s College London (UK) has uncovered the intrinsic and extrinsic effects that circadian disruption can have on muscle health and aging. This disruption, seen with shift work, can affect protein turnover and contribute to muscle wasting. A better understanding of these impacts enables strategies for improving health in shift workers to be developed.

1 week ago | biotechniques.com | Annie Coulson

A global team has analyzed data from nearly 2 million individuals, uncovering new genes and genetic pathways underpinning osteoarthritis. A global collaboration of researchers led by Helmholtz Munich (Germany), including Rush University Medical Center (IL, USA) and 125 academic institutes, conducted the largest genetic investigation into osteoarthritis by analyzing data from nearly 2 million individuals.

3 weeks ago | biotechniques.com | Annie Coulson

Xinyue Chen is in her sixth year as a PhD student in Shawn Liu’s lab and Yueqing Peng’s lab at Columbia University (NY, USA). Xinyue presented her thesis project on the role of methylation in memory consolidation during sleep at the meeting of the Society for Neuroscience (SfN), Neuroscience 2024 (5–9 October; Chicago, IL, USA).

4 weeks ago | biotechniques.com | Annie Coulson

The Center for Predictive in vitro Models (CPM) at Queen Mary University of London (QMUL; UK) brings together over 100 academic staff and post docs who specialize in developing and using organ-on-a-chip (OoC) technology and other types of predictive in vitro models. The center develops models for a broad range of tissues, organs and pathologies, while also conducting research into the underpinning bioengineering that is essential for the development of these models.